With regard to Health Canada: for the last ten years, (a) how many drug safety inspectors has Health Canada employed, broken down by year; (b) how many inspections of pharmaceutical manufacturing companies has Health Canada conducted within Canada, broken down by year; (c) how many pharmaceutical manufacturing companies inspected within Canada have received a warning letter or citation from Health Canada, broken down by year; (d) how many pharmaceutical manufacturing companies inspected within Canada have had penalties imposed, broken down by year; (e) how many pharmaceutical manufacturing companies inspected within Canada have been subject to a ban, broken down by year; (f) how many inspections of pharmaceutical manufacturing companies has Health Canada conducted internationally, broken down by year; (g) how many pharmaceutical manufacturing companies inspected internationally have received a warning letter or citation from Health Canada, broken down by year; (h) how many pharmaceutical manufacturing companies inspected internationally have had penalties imposed, broken down by year; (i) how many pharmaceutical manufacturing companies inspected internationally have been subject to a ban, broken down by year; (j) how many notices of violation concerning companies operating in Canada has Health Canada received from foreign regulators, broken down by year; (k) how many pharmaceutical manufacturing companies has Health Canada inspected because of a notification received from a foreign regulator, broken down by year; (l) how many clinical trials has Health Canada inspected, broken down by year; (m) how many clinical trials received a warning letter or citation from Health Canada following an inspection, broken down by year; (n) how many clinical trials have been shut down by Health Canada following an inspection, broken down by year; (o) how many investigations has Health Canada conducted regarding promotion of off-label prescription of drugs by pharmaceutical companies, broken down by year; (p) how many fines or penalties has Health Canada levied for off-label promotions, broken down by year; (q) how many reports of side effects relating to off-label prescriptions of pharmaceuticals has Health Canada received, broken down by year; and (r) when will Health Canada begin including side effects related to off-label prescriptions in its public database?